MyLab testing kits get ICMR nod


Deprecated: strlen(): Passing null to parameter #1 ($string) of type string is deprecated in /home/medicircle/public_html/script_newsdetails.php on line 75
▴ MyLab testing kits get ICMR nod
Previously, ICMR had approved SD Biosensor, a Korean company for antigen test kits.

India’s very own molecular diagnostics company, Mylab Discovery Solutions, that launched the first indigenous RT-PCR testing kit is now stepping into antigen testing kits with commercial approval from the ICMR. This development now adds another product to Mylab’s suite of testing solutions for the COVID-19 virus.

It is the first truly Indian company kit to receive commercial approval from ICMR and is named as Pathocatch COVID-19 Antigen Rapid testing kit. The launch of an antigen testing kit is in line with the government’s expectation to increase rapid testing which is the Point-of-Care method and complements the more rigorous RT-PCR (Reverse transcription-polymerase chain reaction) test to detect coronavirus. As infections surge across the country, more states are now allowing antigen-based rapid testing in India.

Hasmukh Rawal, MD, Mylab Discovery Solutions said, “Mylab team is working really hard to fight this pandemic in every possible way. After bringing an affordable RT-PCR test to reduce dependence on foreign kits, we launched Compact XL to accelerate COVID-19 testing. Now, with the approval for an antigen testing kit, we will cover whole spectrum of COVID-19 testing and leave no stone unturned to fight this pandemic”

Health experts believe that to keep up with the pace of infections, India needs a combination of both antigen and RT-PCR testing. Those who are found positive in the antigen test are considered positive, while those who get a negative result in antigen tests are then tested with RT-PCR test for confirmation. So, only suspected negative cases go for RT-CR testing. This will save time and cost, hence speed-up the process of testing and isolation.

“While the COVID-19 vaccine gets developed, aggressive testing is an important tool that we have. Mylab is committed to providing high-quality indigenous solutions for testing, which we believe has been possible because we had support from our investors and the government agencies such as BIRAC and TDB to name a few, With all this support, we hope to keep up in this fight” added Mr. Sujit Jain, Director, Mylab.

The kit is developed and manufactured in India. The kit will be available for orders immediately and will be priced around INR 450.

Tags : #MyLabDiscoverySolutions #ICMR #Pathocatch #SDBiosensor #Korea #BIRAC #TBD #HasmukhRawal #AntigenTestKit

About the Author


Team Medicircle

Related Stories

Loading Please wait...

-Advertisements-



Trending Now

Tier-2 and Tier-3 Cities: India's Next Big Healthcare Growth StorySeptember 18, 2026
Why Regional Hospital Chains Are Becoming More Important in IndiaSeptember 18, 2026
The Future of Indian MedTech Exports: Can India Compete With Global Leaders?September 17, 2026
Robotic-Assisted Procedures Beyond Surgery: Where Is Automation Going Next in Healthcare?September 17, 2026
58 Students from SRM Medical College Selected for Union Government Research Programmes and Grants September 16, 2026
Handpickd Questions the Role of Science in Food with ‘Science-Less’ Newspaper CampaignSeptember 16, 2026
As Women’s Cancer Burden Rises, Integrated Care Emerges as The Next Frontier in Cancer TreatmentSeptember 16, 2026
Odia Superstar Babushaan Mohanty Inaugurates Manoj Das Library at Utkal Gaurav International SchoolSeptember 16, 2026
Yashoda Hospitals, Somajiguda Successfully Treats 10-Month-Old with Complex Heart Condition Through Staged ApproachSeptember 16, 2026
Tracky launches 16D, India's first 16-day continuous glucose monitoring system (CGM)September 16, 2026
Why Local Medical Device Manufacturing Matters for Indian HealthcareSeptember 16, 2026
Next-Generation Surgical Robots Entering the Indian Market: What It Means for Patients and ProvidersSeptember 16, 2026
ShardaCare - Healthcity Marks World Sepsis Day with Training for Over 50 NursesSeptember 15, 2026
From Empowerment to Ownership: Upasana Kamineni Konidela Calls for a BRICS Women’s Economic CorridorSeptember 15, 2026
WORLD HEART DAY 2026: Don't Miss a Beat: The Heart Attacks That Never Had to HappenSeptember 15, 2026
BL Agro Announces Investment of ₹1,500 Crore In Its Biotech-Arm Leads Genetics To Build An Integrated Dairy and Genetics EcosystemSeptember 15, 2026
Can You Have PMOS With Regular Periods? What Women Often Get WrongSeptember 15, 2026
Hospital Data Breaches in India: What Every Patient Needs to Know Right NowSeptember 15, 2026
Cybersecurity of ICUs: Protecting Connected Critical-Care Systems in Indian HospitalsSeptember 15, 2026
Fortis Hospital, Shalimar Bagh Becomes Delhi NCR’s First Multi-speciality Hospital to Launch Rezūm™ Water Vapor Therapy for Enlarged ProstateSeptember 14, 2026